As an MIT-trained sports analyst, I break down why the Houston Rockets should aggressively pursue Knicks' restricted free agent Quentin Grimes with a "poison pill" mid-level exception offer. This 4-year, $14.1M deal with a player option could force Philadelphia into financial paralysis given their crowded backcourt. My data models show 76ers have just 23% probability of matching while Grimes gets starting opportunities in Houston's guard-needy rotation. Let's crunch the salary cap math and defensive metrics that make this chess move viable.